The metabolic interactions between tumor cells and tumor-associated stroma (TAS) in prostatic cancer

Cancer Biology and Therapy

Volumn 13, Issue 13, 2012, Pages 1284-1289

  Giatromanolaki, Alexandra ^a   Koukourakis, Michael I ^a   Koutsopoulos, Anastasios ^a   Mendrinos, Savvas ^b   Sivridis, Efthimios ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE MEDICAL SCHOOL   (Greece)

^b Division of Pathology Integrated Medical Professionals   (United States)

Author keywords

Caveolin; Lactate dehydrogenase; Metabolism; Monocarboxylate transporter; Prostate cancer; Thymidine phosphorylase

Indexed keywords

CAVEOLIN 1; LACTATE DEHYDROGENASE; LACTATE DEHYDROGENASE 1; LACTATE DEHYDROGENASE 5; LACTIC ACID; MONOCARBOXYLATE TRANSPORTER 1; PYRUVIC ACID; THYMIDINE PHOSPHORYLASE; UNCLASSIFIED DRUG;

AEROBIC METABOLISM; AGED; ANAEROBIC METABOLISM; ARTICLE; BIOTRANSFORMATION; CANCER CELL; CANCER TISSUE; CELL METABOLISM; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE SEVERITY; EPITHELIUM CELL; FIBROBLAST; GLEASON SCORE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MYOFIBROBLAST; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; STROMA; STROMA CELL; TUMOR ASSOCIATED STROMA;

ADULT; AGED; AGED, 80 AND OVER; CAVEOLIN 1; CELL COMMUNICATION; CELL PROLIFERATION; FIBROBLASTS; HUMANS; ISOENZYMES; L-LACTATE DEHYDROGENASE; LACTATE DEHYDROGENASES; LACTIC ACID; MALE; MIDDLE AGED; MONOCARBOXYLIC ACID TRANSPORTERS; MYOFIBROBLASTS; PROSTATIC NEOPLASMS; PYRUVIC ACID; STROMAL CELLS; SYMPORTERS; THYMIDINE PHOSPHORYLASE; UBIQUITIN-PROTEIN LIGASES;

EID: 84868380040     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.21785     Document Type: Article

References (24)

1. Sivridis E, Giatromanolaki A, Koukourakis MI. "Stromatogenesis" and tumor progression. Int J Surg Pathol 2004; 12:1-9; PMID:14765266; http://dx.doi.org/10.1177/106689690401200101.
2. Giatromanolaki A, Sivridis E, Koukourakis MI. The Pathology of tumor stromatogenesis. Cancer Biol Ther 2007; 6:6; PMID:17534144.
3. Cunha GR, Hayward SW, Wang YZ, Ricke WA. Role of the stromal microenvironment in carcinogenesis of the prostate. Int J Cancer 2003; 107:1-10; PMID:12925950; http://dx.doi.org/10.1002/ijc.11335.
4. Thompson TC, Timme TL, Kadmon D, Park SH, Egawa S, Yoshida K. Genetic predisposition and mesenchymal-epithelial interactions in ras+myc-induced carcinogenesis in reconstituted mouse prostate. Mol Carcinog 1993; 7:165-79; PMID:8489712; http://dx.doi.org/10.1002/mc.2940070307.
5. Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N, Shappell S, et al. TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 2004; 303:848-51; PMID:14764882; http://dx.doi.org/10.1126/ science.1090922.
6. Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 1999; 59:5002-11; PMID:10519415.
7. Koukourakis MI, Giatromanolaki A, Brekken RA, Sivridis E, Gatter KC, Harris AL, et al. Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients. Cancer Res 2003; 63:5376-80; PMID:14500371.
8. Sivridis E, Giatromanolaki A, Anastasiadis P, Georgiou L, Gatter KC, Harris AL, et al.; Tumour and Angiogenesis Research Group. Angiogenic co-operation of VEGF and stromal cell TP in endometrial carcinomas. J Pathol 2002; 196:416-22; PMID:11920737; http://dx.doi.org/10.1002/path.1060.
9. Lagace R, Grimaud JA, Shurch W, et al. Myofibroblastic stromal reaction in carcinomas of the breast and variations of collagenous matrix and structural glycoproteins. Virchows Arch 1985; 408:49-59; http://dx.doi.org/10.1007/ BF00739962.
10. Parton RG, Hanzal-Bayer M, Hancock JF. Biogenesis of caveolae: a structural model for caveolin-induced domain formation. J Cell Sci 2006; 119:787-96; PMID:16495479; http://dx.doi.org/10.1242/jcs.02853.
11. Witkiewicz AK, Dasgupta A, Sotgia F, Mercier I, Pestell RG, Sabel M, et al. An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers. Am J Pathol 2009; 174:2023-34; PMID:19411448; http://dx.doi.org/10.2353/ajpath.2009.080873.
12. Goetz JG, Minguet S, Navarro-Lérida I, Lazcano JJ, Samaniego R, Calvo E, et al. Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis. Cell 2011; 146:148-63; PMID:21729786; http://dx.doi.org/10.1016/j.cell.2011.05.040.
13. Koukourakis MI, Giatromanolaki A, Harris AL, Sivridis E. Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma. Cancer Res 2006; 66:632-7; PMID:16423989; http://dx.doi.org/10.1158/0008-5472.CAN-05-3260.
14. Koukourakis MI, Giatromanolaki A, Bougioukas G, Sivridis E. Lung cancer: a comparative study of metabolism related protein expression in cancer cells and tumor associated stroma. Cancer Biol Ther 2007; 6:1476-9; PMID:17881895; http://dx.doi.org/10.4161/cbt.6.9.4635.
15. Griffiths L, Stratford IJ. Platelet-derived endothelial cell growth factor thymidine phosphorylase in tumour growth and response to therapy. Br J Cancer 1997; 76:689-93; PMID:9310231; http://dx.doi.org/10.1038/bjc.1997.447.
16. Sivridis E, Giatromanolaki A, Papadopoulos I, Gatter KC, Harris AL, Koukourakis MI. Thymidine phosphorylase expression in normal, hyperplastic and neoplastic prostates: correlation with tumour associated macrophages, infiltrating lymphocytes, and angiogenesis. Br J Cancer 2002; 86:1465-71; PMID:11986782; http://dx.doi.org/10.1038/sj.bjc.6600281.
17. Okada K, Yokoyama K, Okihara K, Ukimura O, Kojima M, Miki T, et al. Immunohistochemical localization of platelet-derived endothelial cell growth factor expression and its relation to angiogenesis in prostate. Urology 2001; 57:376-81; PMID:11182368; http://dx.doi.org/10.1016/S0090-4295(00)00907-9.
18. Sivridis E, Giatromanolaki A, Koukourakis MI, Bicknell R, Harris AL, Gatter KC. Thymidine phosphorylase expression in endometrial carcinomas. Clin Exp Metastasis 1999; 17:445-50; PMID:10651312; http://dx.doi.org/10.1023/A: 1006603709248.
19. Koukourakis MI, Giatromanolaki A, Kakolyris S, O'Byrne KJ, Apostolikas N, Skarlatos J, et al. Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small-cell lung cancer: impact on tumour neoangiogenesis and survival. Br J Cancer 1998; 77:1696-703; PMID:9635852; http://dx.doi.org/10.1038/bjc.1998.280.
20. Di Vizio D, Morello M, Sotgia F, Pestell RG, Freeman MR, Lisanti MP. An absence of stromal caveolin-1 is associated with advanced prostate cancer, metastatic disease and epithelial Akt activation. Cell Cycle 2009; 8:2420-4; PMID:19556867; http://dx.doi.org/10.4161/cc.8.15.9116.
21. Pavlides S, Whitaker-Menezes D, Castello-Cros R, Flomenberg N, Witkiewicz AK, Frank PG, et al. The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma. Cell Cycle 2009; 8:3984-4001; PMID:19923890; http://dx.doi.org/10.4161/cc.8.23.10238.
22. Rattigan YI, Patel BB, Ackerstaff E, Sukenick G, Koutcher JA, Glod JW, et al. Lactate is a mediator of metabolic cooperation between stromal carcinoma associated fibroblasts and glycolytic tumor cells in the tumor microenvironment. Exp Cell Res 2012; 318:326-35; PMID:22178238; http://dx.doi.org/10.1016/j. yexcr.2011.11.014.
23. Warburg O. The Metabolism of Tumors. London, United Kingdom: Constable & Co. Ltd 1930.
24. Harris AL. Metabolic compartments in tumor tissue: implications for therapy. Cell Cycle 2012; 11:13-4; PMID:22193036; http://dx.doi.org/10.4161/cc. 11.1.18729.